- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · May 12, 2026 | 7.2M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 9.74M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 8.87M sh |
| Shares Diluted restated | Q2 2026 · Mar 31, 2025 | 118.21K sh |
| Shares Diluted restated | Q2 2026 · Mar 31, 2025 | 88.26K sh |
| Cash And Equivalents | Q2 2026 · Mar 31, 2026 | $949.09K |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $1.67M |
| Stockholders Equity | Q2 2026 · Mar 31, 2026 | $12.51M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $2.3M |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $1.47M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $2.46M |
| Total Liabilities | Q2 2026 · Mar 31, 2026 | $1.5M |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $2.5M |
| Current Assets | Q2 2026 · Mar 31, 2026 | $2.68M |
| Current Assets | Q2 2026 · Sep 30, 2025 | $2.24M |
| Total Assets | Q2 2026 · Mar 31, 2026 | $13.63M |
| Total Assets | Q2 2026 · Sep 30, 2025 | $4.44M |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | −$0.68 |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | −$2.85 |
| Eps Diluted restated | Q2 2026 · Mar 31, 2025 | −$230.30 |
| Eps Diluted restated | Q2 2026 · Mar 31, 2025 | −$507.25 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | −$0.68 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | −$2.85 |
| Eps Basic restated | Q2 2026 · Mar 31, 2025 | −$230.30 |
| Eps Basic restated | Q2 2026 · Mar 31, 2025 | −$507.25 |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $2.59M |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $15.94M |
| Sga Expense restated | Q2 2026 · Mar 31, 2025 | $2.92M |
| Sga Expense restated | Q2 2026 · Mar 31, 2025 | $5.49M |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $372.15K |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $830.71K |
| Rd Expense | Q2 2026 · Mar 31, 2025 | $849.36K |
| Rd Expense | Q2 2026 · Mar 31, 2025 | $1.86M |
| Net Income | Q2 2026 · Mar 31, 2026 | −$6.67M |
| Net Income | Q2 2026 · Mar 31, 2026 | −$25.26M |
| Net Income | Q2 2026 · Mar 31, 2025 | −$3.3M |
| Net Income | Q2 2026 · Mar 31, 2025 | −$5.94M |
| Operating Income | Q2 2026 · Mar 31, 2026 | −$6.75M |
| Operating Income | Q2 2026 · Mar 31, 2026 | −$25.46M |
| Operating Income restated | Q2 2026 · Mar 31, 2025 | −$3.38M |
| Operating Income restated | Q2 2026 · Mar 31, 2025 | −$6.36M |
| Gross Profit | Q2 2026 · Mar 31, 2026 | $826.79K |
| Gross Profit | Q2 2026 · Mar 31, 2026 | $1.14M |
| Gross Profit restated | Q2 2026 · Mar 31, 2025 | $395.52K |
| Gross Profit restated | Q2 2026 · Mar 31, 2025 | $1M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $197.33K |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $447.36K |
| Cost Of Revenue restated | Q2 2026 · Mar 31, 2025 | $367.3K |
| Cost Of Revenue restated | Q2 2026 · Mar 31, 2025 | $631.36K |
| Capex | Q2 2026 · Mar 31, 2025 | $302.2K |